Shuttle Pharmaceuticals Holdings, Inc. Common Stock

Go to Shuttle Pharmaceuticals Holdings, Inc. Common Stock Website

$3.76

0.13 (3.58%)
Live
Previous Close

$3.63

Day Range

$3.56 - $3.83

Previous Day Range

$3.41 - $3.73

Market Cap

$1.6 million USD

Day Vol.

58873

Previous Day Vol.

34127

Currency

USD

Primary Exchange

Nasdaq

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery,...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) announced the closing of a $5.75 million underwritten public offering. The company plans to use the proceeds to fund its Phase II clinical trial, marketing, and general corporate purposes.

Related tickers: SHPH.

Read Full Article

Shuttle Pharmaceuticals has successfully dosed the first three patients in its Phase 2 clinical trial of Ropidoxuridine for the treatment of glioblastoma, a deadly brain cancer. The company has also finalized agreements with six clinical trial sites and raised additional funding to support the trial.

Related tickers: SHPH.

Read Full Article
Trending Tickers

Please sign in to view